Showing results (301-310 of 348) with videos related to
Sort By:
Pageof 35
Arteriosclerosis, Thrombosis, and Vascular Biology|April 11, 2015
Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsisSimon Lambden, Peter Kelly, Blerina Ahmetaj-Shala, et al.Journal of the Intensive Care Society|August 29, 2022
Cellular and molecular mechanisms of IMMunE dysfunction and Recovery from SEpsis-related critical illness in adults: An observational cohort study (IMMERSE) protocol paperMatthew Fish, Kate Arkless, Aislinn Jennings, et al.The New England Journal of Medicine|October 6, 2016
Levosimendan for the Prevention of Acute Organ Dysfunction in SepsisAnthony C Gordon, Gavin D Perkins, Mervyn Singer, et al.Intensive Care Medicine|June 16, 2026
Current knowledge and challenges of sepsis-associated encephalopathyManu Shankar-Hari, Sarah Benghanem, Lena Bourhy, et al.Trials|November 21, 2018
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trialMartin Unger, Andrea Morelli, Mervyn Singer, et al.Plos Medicine|November 16, 2012
Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitisPeter Recknagel, Falk A Gonnert, Martin Westermann, et al.Proceedings of the National Academy of Sciences of the United States of America|July 31, 2015
Key bioactive reaction products of the NO/H2S interaction are S/N-hybrid species, polysulfides, and nitroxylMiriam M Cortese-Krott, Gunter G C Kuhnle, Alex Dyson, et al.JAMA|October 25, 2023
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical TrialTony Whitehouse, Anower Hossain, Gavin D Perkins, et al.Intensive Care Medicine|October 21, 2024
Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsisJ Kenneth Baillie, Derek Angus, Katie Burnham, et al.British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.Pageof 35